The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms
Open accessAbstract
BACKGROUND: A set of symptoms common across cancers has been proposed to enhance quality of care and clinical research in solid tumor patients. Using data from several clinical studies, this study evaluated these symptoms in primary brain tumor patients. METHODS: Symptom report data using the MD Anderson Symptom Instrument -Brain Tumor (MDASI-BT) from 621 patients enrolled in 8 clinical studies was used. The prevalence and severity of symptoms were reported as they relate to tumor grade, treatment stage and KPS. RESULTS: The sample was primarily white (82.5%) males (59%) with high-grade gliomas (75%). More than 50% of patients reported at least 10 concurrent symptoms, and 40% of patients reporting having at least 3 moderate-to-severe symptoms. Fatigue, drowsiness, difficulty remembering, disturbed sleep, and distress were the most severe symptoms reported by all tumor grades. Functional interference of symptoms with ability to work, perform activities, walk, and enjoy life was reported by more than 25% of patients. CONCLUSIONS: These results support a core set of symptoms, common in other solid tumor patients, that may impact clinical care and assessment of treatment benefit. Although only 5 of the Center for Medical Technology Policy list of proposed core symptoms met criteria for inclusion in this sample, 5 of the other proposed core symptoms were also reported in similar frequency as reported in the other cancer populations. This primary brain tumor population differed from other solid tumor patients in that other symptoms, which could be disease related, were more prevalent and thus should also be collected for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834 · cited 1×
“In addition, MDASI-BT has been shown to be predictive of survival outcomes and between arm differences in randomized clinical trials.(4,19) Interestingly, we found some symptoms to be more prevalent in lower-grade tumor patients and those patients not on active treatment.”
BackgroundSelf-citationCleeland, C. S., Zhao, F., Chang, V. T., Sloan, J. A., O'Mara, A. M., Gilman, P. B., Weiss, M., Mendoza, T. R., Lee, J., & Fisch, M. J. (2013) · Cancer · doi:10.1002/cncr.28376 · Cited by 316
Self-citation
Cited by
Snijders, R., Brom, L., Theunissen, M., & van den Beuken-van Everdingen, M. (2023) · Cancers · doi:10.3390/cancers15030591 · Cited by 445
Prevalence and risk factors of cancer-related fatigue: A systematic review and meta-analysis
Ma, Y., He, B., Jiang, M., Yang, Y., Wang, C., Huang, C., & Han, L. (2020) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2020.103707 · Cited by 326
Well-being and coping: key aspects of unmet need of people living with glioma
Baddeley, E., Sivell, S., Retzer, A., Nelson, A., Bulbeck, H., Seddon, K., Grant, R., Adams, R., Watts, C., Aiyegbusi, O. L., et al. (2025) · Neuro-Oncology Practice · doi:10.1093/nop/npae127 · Cited by 6
Metadata
- Authors
- Armstrong, T. S., Vera-Bolanos, E., Acquaye, A. A., Gilbert, M. R., Ladha, H., & Mendoza, T.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-19
- Volume
- 18
- Issue
- 2
- Pages
- 252-260
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2127850846
- Cited by
- 165
- References
- 2
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.